<P ALIGN="JUSTIFY"> Kallmann Syndrome is a hereditary disease that exists in both X-linked and autosomal forms and is characterized by anosmia (inability to smell) and infertility. Additionally, affected patients display kidney malformations or even lack one kidney. Detailed analyses of the anosmic phenotype showed a specific defect in olfactory axons that fail to make connections with their interneuronal targets while their pathfinding seems unaffected. For the X-linked form a gene called Kal-1 was identified (1,2) that codes for a secreted protein containing FNIII modules and a protease inhibitor domain. However, the genetic lesions responsible for the autosomal forms, that could reside e.g. in a putative receptor gene, remain elusive. <P ALIGN="JUSTIFY"> We identified Cekal-1 , an ortholog of the human Kallmann Syndrome gene Kal-1 , in C. elegans . CeKAL-1 shows a high structural homology to human Kal-1 and is expressed in subsets of neurons in C. elegans as well as in non-neuronal tissues e.g. the excretory cell. To identify loci that genetically interact with Cekal-1 we employed a two step approach. We first generated a gain-of-function ( gf ) phenotype by over/misexpressing the Cekal-1 cDNA and then searched for mutations that modified this phenotype by both testing candidate mutations and performing a genetic screen. <FONT SIZE="2" FACE="Helvetica">When we overexpressed Cekal-1 in AIY, a pair of interneurons, in a strain carrying a GFP reporter that labeled these neurons, 100% of the animals displayed ectopic neurites originating from the cell body and/or the axons of AIY. We tested whether these neurites were specific for Cekal-1 by expressing a truncated form of CeKAL-1 in AIY. This, as well as expression of related proteins had no effect in AIY interneurons suggesting the phenotype in AIY to be specific for expression of CeKAL-1. Mis/overexpression using a pan-neuronal promoter also leads to visible neuroanatomical defects in many but not all neurons (see poster by Berry et al. ). <FONT SIZE="2" FACE="Helvetica">The AIY specific neurite outgrowth defect could not be modified by mutations in genes required for axonal pathfinding including
unc-6 ,
unc-5 ,
unc-40 ,
unc-73 ,
sax-3 ,
vab-1 , and
ina-1 indicating that these genes do not have a role in the generation of the observed neurites. However, some exc genes that had previously been identified in a screen for animals with defects in the excretory canal (3) efficiently suppressed our gf phenotype. This is insofar of significance as the excretory canal is believed to be the functional equivalent of the mammalian kidney. Thus, the biological function of the Kallmann Syndrome protein in neuronal guidance as well as development of kidney-like structures could be conserved throughout evolution <FONT SIZE="2" FACE="Helvetica">To identify additional interacting loci we performed a suppressor/modifier screen of the gf phenotype. In a small screen we identified at least 6 mutants (
ot16-
ot20,
ot24 ) in 4 complementation groups that efficiently suppressed the sprouting phenotype to various degrees between 25-80%. Interestingly we also found one mutant (
ot21 ) that qualitatively enhanced the axonal sprouting phenotype. We assessed the specificity of the modifier mutations by constructing double mutants of these mutations with
ttx-3(
ks5 ) or
sax-2(
ot10) , both mutants that lead to neurite outgrowth phenotypes in AIY or sensory neurons. Our modifier mutations did not modify these phenotypes suggesting specific modification of the Cekal-1 dependent neurites. <P ALIGN="JUSTIFY"> We have started to characterize the isolated modifier mutations molecularly. Using a combination of 3-factor mapping, deficiencies and single nucleotide polymorphisms we were able to map two of the strong suppressor mutations
ot16III and
ot17X to a small intervals.
ot16III maps to a six cosmid interval between
unc-79 and
emb-5 on LGIII and
ot17X to seven cosmids between
lon-2 and
unc-97 on LGX. We are currently attempting tranformation rescue by injecting cosmids of the respective regions. 1. Franco B, Guiloli S, Pragliola A, et al. (1991) Nature , 353:529-536 <FONT SIZE="2" FACE="Helvetica">2. Legouis R, Hardelin JP, et al. (1991) Cell , 67:423-435 <FONT SIZE="2" FACE="Helvetica">3. Buechner et al. (1999) Dev. Biol. 214:227-241